Arca
Skip to content
Tools
Tools

Falciparum malaria

Drug research and approvals for falciparum malaria: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 20 studies of falciparum malaria are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, FDA has 1 approved and 0 open orphan designations naming it, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 20
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 1
  • EU medicines: 1

Recruiting now

Newest posted first, of 20 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 2

Phase 3 12 of 20

Phase 2 12 of 13

Phase 1 or earlier 7

How its trials ended

338 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 140 whose ending is known, 63% met their primary endpoint, 14% missed it and 24% stopped early.

  • Completed, result not reported13741%
  • Met its primary endpoint8826%
  • Ongoing3410%
  • Status unknown278%
  • Stopped: other or unclear237%
  • Missed its primary endpoint196%
  • Stopped: lack of efficacy31%
  • Stopped: sponsor or business decision31%
  • Stopped: funding21%
  • Stopped: safety1<1%
  • Stopped: enrollment or feasibility1<1%

FDA orphan designations

Approved first, then open designations, newest first
DateDrugSponsorStatus
Aug 12, 2005Quinine SulfateTreatment of uncomplicated Plasmodium falciparum malariaAR Holding Company, Inc.Approved

Medicines authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Oct 27, 2011EurartesimPiperaquine tetraphosphate; artenimolAlfasigma S.p.A.EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.